<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Glaucoma is an optic neuropathy usually but not always associated with raised intraocular pressure. It is the second leading cause of preventable blindness in the world. Chronic Glaucoma may produce severe loss of vision and blindness without prior  warning  symptoms and must therefore be screened for in all adults beyond the age of 40 years. Acute glaucoma is however associated with very high intraocular pressures and very severe pain and inflammation of the eye and can lead to blindness quickly if not treated. When congenital, glaucoma causes enlargement of the eyeball associated with increased sensitivity to light and watering.</p><p>Pharmacological treatment may vary from patient to patient according to local availability, affordability, and individual response to treatment.</p><p><strong>CAUSES</strong></p><ul><li>Acute closure of the drainage angle (due to pupil block in primary angle closure glaucoma)</li><li>Inadequate drainage of aqueous from the anterior chamber (despite open drainage angles in chronic open angle glaucoma)</li><li>Neovascular membrane in the drainage angle in ischaemic eye diseases such as proliferative diabetic retinopathy</li><li>Displaced lens in secondary angle closure glaucoma</li><li>Malformation of the drainage angle in congenital glaucoma</li></ul><p><strong>SYMPTOMS AND SIGNS</strong></p><div class="table"><table><tbody><tr><td colspan="4"><strong> Table 19-3: Characteristics of the various types of the common types of Glaucoma</strong></td></tr><tr><td>Symptoms and signs</td><td>Chronic open angle</td><td>Acute angle closure</td><td>Congenital</td></tr><tr><td>Onset</td><td>Usually 40 years and above</td><td>Elderly</td><td>Infants and toddlers</td></tr><tr><td>Symptoms</td><td>Nil till late then progressive visual loss</td><td>Sudden visual loss, Severe eye pain, very inflamed eye, watery discharge, headache and vomiting sometimes</td><td>Photophobia, watering,</td></tr><tr><td>Intraocular pressure</td><td>Usually high, may be normal</td><td>Very high</td><td>High</td></tr><tr><td>Cornea</td><td>Normal</td><td>Hazy</td><td>Enlarged and hazy with linear breaks</td></tr></tbody></table></div><p><strong>INVESTIGATIONS</strong></p><ul><li>Gonioscopy</li><li>Central retinal thickness measurement</li><li>Visual field analysis</li><li>Optic Disc photography</li><li>Retinal Nerve Fibre Thickness Analysis</li><li>Examination of children under anaesthesia</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To prevent progression of the disease and halt further deterioration</li></ul><p>of vision</p><ul><li>To normalise intraocular pressure</li></ul><p><strong>Non-pharmacological treatment</strong></p><ul><li>Drainage Surgery</li><li>Laser Surgery</li><li>Glaucoma Drainage device</li><li>Various other implants</li></ul><p><strong>Pharmacological treatment</strong></p><div class="table"><table><tbody><tr><td><strong>Note 19-1</strong></td></tr><tr><td>Consult an ophthalmologist on the treatment of glaucoma.</td></tr></tbody></table></div><p> </p><p>  1st Line Treatment Evidence Rating: [B]</p><p>Treatment is with one medication from one or more of the following groups:</p><ul><li>Latanoprost, eye drops, 50 microgram/ml</li><li>Bimatoprost, eye drops, 300 microgram/ml</li><li>Travoprost, eye drops, 40 microgram/ml</li></ul><p><strong>And/Or</strong></p><ul><li>Timolol 0.5% eye drops</li><li>Levobunolol 0.5% eye drops</li><li>Betaxolol 0.5% eye drops</li></ul><p><strong>And /Or</strong></p><ul><li>Brimornidine, 1 mg/ml or 1.5 mg/ml</li></ul><p><strong>And/Or</strong></p><ul><li>Acetazolamide, oral, 250 mg</li><li>Brinzolamide, eye drops, 10 mg/ml</li><li>Dorzolamide, eye drops, 20 mg/ml</li></ul><p><strong>And/Or</strong></p><ul><li>Pilocarpine 1-4%, eye drops</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p>Refer all suspected cases of glaucoma to the ophthalmologist for assessment and initial treatment.</p>
</body>
</html>
